HCG25: A Potential Drug Target Or Biomarker (G414765)

Target Name: HCG25

NCBI ID: G414765

HCG25

Other Name(s): dJ1033B10.16 | HLA complex group 25

HCG25: A Potential Drug Target Or Biomarker

Human chorionic gonadotropin-25 (HCG25), also known as dJ1033B10.16, is a glycoprotein hormone produced by the placenta during pregnancy. It is a key protein involved in the development and maintenance of pregnancy, and has been widely studied as a potential drug target or biomarker.

HCG25 is a glycoprotein that consists of four chains: alpha, beta, gamma, and delta. It is found in the urine and feces of pregnant women, and its levels tend to increase significantly following the first trimester of pregnancy. The levels of HCG25 peaked around the 10th week of pregnancy and decay over time.

One of the key functions of HCG25 is its role in the development and maintenance of pregnancy. During pregnancy, HCG25 plays a vital role in the formation and growth of new tissues, including the placenta, fetal organs, and nervous system. It is also involved in the regulation of fetal growth and development, and has been shown to have a positive impact on the health and survival of newborns.

In addition to its role in pregnancy, HCG25 has also been found to have a number of potential drug-related properties. For example, studies have shown that HCG25 can be used as a biomarker for various diseases, including cancer, cardiovascular disease, and neurological disorders. Its levels have also been shown to be elevated in individuals with certain genetic mutations, which may suggest a role for HCG25 in the development of certain diseases.

Another potential use for HCG25 is as a drug target. The levels of HCG25 have been shown to be elevated in individuals with certain genetic mutations, which may suggest a role for HCG25 in the development and progression of these mutations. Additionally, HCG25 has been shown to interact with a number of different proteins, including the insulin-like growth factor 1 (IGF-1) and the transforming growth factor beta (TGF-β). This suggests that HCG25 may play a role in the regulation of cellular processes that are important for both normal growth and development.

Overall, HCG25 is a protein that has been widely studied as a potential drug target or biomarker. Its role in the development and maintenance of pregnancy, as well as its potential as a biomarker and drug target, makes it an important area of research for scientists and clinicians. Further studies are needed to fully understand the properties and functions of HCG25, and to determine its potential as a therapeutic agent.

Protein Name: HLA Complex Group 25

The "HCG25 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HCG25 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets